ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Critical Care Medicine

Top Critical Care Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARC MELAMED MD

Critical Care Medicine

4,341

$420K

309
295 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 55%

$97
Average prescription price

Avg: $155

PANDE JOSIFOVSKI M.D.

Critical Care Medicine

4,299

$363K

173
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 55%

$84
Average prescription price

Avg: $155

RAO MIKKILINENI MD

Critical Care Medicine

3,722

$366K

152
123 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 55%

$98
Average prescription price

Avg: $155

VIPIN GARG M.D.

Critical Care Medicine

3,415

$448K

371
221 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 55%

$131
Average prescription price

Avg: $155

ERIC JACKSON M.D.

Critical Care Medicine

2,819

$268K

175
141 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 55%

$95
Average prescription price

Avg: $155

EIN YUAN SHEN MD

Critical Care Medicine

2,598

$241K

173
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 55%

$93
Average prescription price

Avg: $155

KEITH GOLDSTEIN MD

Critical Care Medicine

2,500

$582K

244
206 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 55%

$233
Average prescription price

Avg: $155

SEKAR NATARAJAN M.D.

Critical Care Medicine

2,112

$154K

161
138 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 55%

$73
Average prescription price

Avg: $155

NANCY HIGGINS M.D.

Critical Care Medicine

1,667

$664K

301
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 55%

$398
Average prescription price

Avg: $155

DANIEL CHU

Critical Care Medicine

1,271

$113K

67
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 55%

$89
Average prescription price

Avg: $155

NADIA SADIK M.D.

Critical Care Medicine

1,147

$262K

213
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 55%

$228
Average prescription price

Avg: $155

MARTIN LANSANG M.D.

Critical Care Medicine

968

$193K

209
173 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 55%

$200
Average prescription price

Avg: $155

MARC ADELMAN M.D.

Critical Care Medicine

743

$98.4K

89
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 55%

$132
Average prescription price

Avg: $155

FRANCES LOFTUS DO

Critical Care Medicine

715

$254K

161
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 55%

$355
Average prescription price

Avg: $155

MANUEL CUNANAN M.D.

Critical Care Medicine

647

$130K

166
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 55%

$201
Average prescription price

Avg: $155

JAIME MOLINA-MARINEZ M.D.

Critical Care Medicine

533

$643K

102
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 55%

$1207
Average prescription price

Avg: $155

TANUJ BHATNAGAR MD

Critical Care Medicine

223

$33.2K

66
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 55%

$149
Average prescription price

Avg: $155

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank